APOC3 and venous thromboembolism: Our most notable findings were the associations between genetically predicted triglycerides and decreased risk of thromboembolic diseases both in polygenic analyses and in gene-specific analyses for the APOC3 gene region, suggesting that reducing triglycerides may increase risk for venous thromboembolism.